Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksIp Group Share News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.00
Bid: 50.80
Ask: 51.20
Change: 0.80 (1.59%)
Spread: 0.40 (0.787%)
Open: 50.20
High: 51.10
Low: 50.20
Prev. Close: 50.20
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: Ocado invests in autonomous vehicle software firm Oxbotica

Fri, 16th Apr 2021 07:47

(Alliance News) - Ocado Group PLC on Friday said it is investing GBP10 million in autonomous vehicle software company Oxbotica Ltd.

Oxbotica was founded in 2014 as an Oxford University spin-out.

Ocado's investment is part of a commercial partnership between the two to collaborate on hardware and software interfaces for autonomous vehicles, enhancing and integrating Oxbotica's autonomy software platform into a variety of vehicles.

The use cases range from vehicles that operate inside of Ocado's Customer Fulfilment Centre warehouses, to last-mile deliveries and "kerb-to-kitchen robots".

"This will be a multi-year collaboration, and the ultimate ambition is to enable Ocado's partners that use the Ocado Smart Platform to reduce the costs of last-mile delivery and other logistics operations," said Ocado.

The two began working together in 2017, when Ocado conducted a two week trial using an early prototype delivery vehicle doing autonomous deliveries in Greenwich, London. Since then, Ocado said Oxbotica has made "significant progress" in developing its platform, leading to Friday's announcement of the FTSE 100 constituent's financial injection and commercial collaboration.

Ocado will invest as part of Oxbotica's latest series B funding round and will take a seat on Oxbotica's board.

The round was led by bp ventures, and included other investors such as Tencent Holdings Ltd, Halma PLC and IP Group PLC.

Beyond potential cost savings within its core operations, Ocado said it sees scope to improve its partners' customer proposition.

For both regulatory and "complexity" reasons, Ocado expects that the development of vehicles that operate inside its CFCs may become a reality sooner than fully-autonomous deliveries to consumers' homes.

"However, all aspects of autonomous vehicle development will be within the scope of this collaboration. Ocado expects to see the first prototypes of some early use cases for autonomous vehicles within two years," said Ocado.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Nov 2021 09:18

IP Group portfolio company inks joint development agreement with Ceres Power

(Sharecast News) - Intellectual property company IP Group said on Thursday that portfolio company RFC Power, a long-duration energy storage company, had signed a joint development agreement with fuel cell technology firm Ceres Power.

Read more
29 Oct 2021 14:36

IN BRIEF: IP Group investee Hinge Health valued at over USD6 billion

IN BRIEF: IP Group investee Hinge Health valued at over USD6 billion

Read more
25 Oct 2021 16:10

IN BRIEF: IP Group books GBP27.5 million fair value gain

IN BRIEF: IP Group books GBP27.5 million fair value gain

Read more
25 Oct 2021 08:42

IP Group records £27.5m value gain after recent funding round

(Sharecast News) - Intellectual property-based business developer IP Group said on Monday that, following the completion of a funding round by a portfolio company in its top 20 most valuable holdings, it recorded a net realised and unrealised fair value gain of about £27.5m, or 2.6p per share.

Read more
19 Oct 2021 10:50

Oxford BioMedica licences technology for cystic fibrosis treatment

Oxford BioMedica licences technology for cystic fibrosis treatment

Read more
19 Oct 2021 09:18

Boehringer Ingelheim licenses Oxford Biomedica's lentiviral vector technology

(Sharecast News) - Gene and cell therapy firm Oxford Biomedica said on Tuesday that pharmaceutical giant Boehringer Ingelheim had exercised its option to license its lentiviral vector technology to manufacture, register and commercialise a treatment for cystic fibrosis.

Read more
12 Oct 2021 14:40

IN BRIEF: Outgoing IP Group CEO Alan Aubrey buys 40,000 shares

IN BRIEF: Outgoing IP Group CEO Alan Aubrey buys 40,000 shares

Read more
6 Oct 2021 12:11

LONDON MARKET MIDDAY: Shares fall as gas prices fuel inflation fear

LONDON MARKET MIDDAY: Shares fall as gas prices fuel inflation fear

Read more
6 Oct 2021 09:26

IP Group CEO, CIO step down after Oxford Nanopore IPO

(Sharecast News) - IP Group said on Wednesday that chief executive Alan Aubrey and chief investment officer Mike Townend are retiring and stepping down from the board with immediate effect following the successful flotation of its largest holding, Oxford Nanopore Technologies.

Read more
6 Oct 2021 09:18

TOP NEWS: Oxford Nanopore IPO prompts change at top at IP Group

TOP NEWS: Oxford Nanopore IPO prompts change at top at IP Group

Read more
30 Sep 2021 12:11

LONDON MARKET MIDDAY: Stocks mixed; Oxford Nanopore soars on debut

LONDON MARKET MIDDAY: Stocks mixed; Oxford Nanopore soars on debut

Read more
30 Sep 2021 10:47

UPDATE: Oxford Nanopore nears GBP5 billion value in London debut

UPDATE: Oxford Nanopore nears GBP5 billion value in London debut

Read more
30 Sep 2021 10:42

Shares soar as Oxford Nanopore makes its London debut

(Sharecast News) - Shares in Oxford Nanopore Technologies surged on Thursday after the British biotech made its £3.4bn debut on the London Stock Exchange.

Read more
30 Sep 2021 09:49

TOP NEWS: Oxford Nanopore hits GBP4.6 billion value in London debut

TOP NEWS: Oxford Nanopore hits GBP4.6 billion value in London debut

Read more
20 Sep 2021 16:04

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.